INTRODUCTION
The ability of mononuclear phagocytes (monocytes, macrophages) to kill intracellular pathogens depends in part on the capacity of these cells to generate potentially toxic oxygen metabolites (1) (2) (3) (4) (5) (6) . The membrane perturbation induced by phagocytosis initiates a burst of respiratory activity and the increased oxygen consumed is converted to the superoxide anion (05)', H202, hydroxyl radical (OH"), and possibly singlet molecular oxygen (102) (7) . The initial product of the respiratory burst, O2, appears to have little direct toxic activity; however its dismutation product, H202, and the products of the metal-catalyzed interaction of O2 and H202, i.e., OH and possibly '02, are microbicidal and cytotoxic, and appear to serve this function in mononuclear phagocytes (3, 5) . Oxygen-dependent microbicidal activity requires production of these toxic products of oxygen reduction and excitation in amounts sufficient to overcome the protective capacity of the endogenous scavengers present in the pathogen (8, 9) . Resident macrophages exhibit a weak respiratory burst and are relatively inactive against intracellular pathogens; in contrast, immunologically activated macrophages and circulating phagocytes have both a more pronounced respiratory burst and enhanced microbicidal activity against these organisms (2, (4) (5) (6) (10) (11) (12) (13) (14) .
Blood phagocytes contain a peroxidase in cytoplasmic granules (myeloperoxidase [MPO] in neutrophils and monocytes, eosinophil peroxidase [EPO] in eosinophils), which greatly potentiates the antimicrobial activity of H202 in the presence of a halide (15, 16) . Macrophages lack a granule peroxidase (1) and thus do not generally utilize this mechanism for the amplification of H202-dependent antimicrobial activity. It is possible, however, that macrophages can utilize peroxidase released by peroxidase-positive phagocytes at the inflammatory site. EPO, and to a lesser degree MPO, are cationic proteins that bind firmly to the surface of microorganisms with the retention of peroxidatic activity (17, 18) . Peroxidase taken up by macrophages, either on the surface of ingested organisms (18) , by pinocytosis of fluid-phase peroxidase (19) , or by the phagocytosis of leukocytic debris (20) (21) (22) , might be expected to enhance the microbicidal activity of these cells.
In this study, we used Toxoplasma gondii to explore the potential role of acquired peroxidase in the killing of intracellular pathogens by mononuclear phagocytes. T. gondii is rich in catalase and superoxide dismutase (23) and is thus resistant to the small amounts of oxygen metabolites produced by resident mouse peritoneal macrophages and human monocyte-derived macrophages (2, 3) ; Toxoplasma survive and replicate within these cells. We report here that highly purified EPO, bound to the surface of T. gondii, augments the toxoplasmacidal activity of resident murine macrophages. Further, monocytes from patients with hereditary MPO deficiency have a defect in toxoplasmacidal activity during the early postphagocytic period, which is reversed by the presence of EPO on the surface of the organism. Our data suggest a mechanism by which acquired peroxidase may augment the killing of intracellular pathogens by mononuclear phagocytes and thus contribute to host defense before the development of macrophage activation.
METHODS

Parasites
T. gondii (RH strain). The parasite was maintained and processed as previously described (24) , except that organisms were harvested from the peritoneal cavity of mice in 0.1 M sodium phosphate buffer, pH 7.2 (PB) rather than in phosphate buffer containing sodium chloride (PBS). After filtration through a 3-Mm polycarbonate membrane filter (Nuclepore Corp., Pleasanton, CA) to remove leukocytes, organisms were collected by centrifugation at 200g for 10 min and resuspended in PB.
Binding of EPO to Toxoplasma. EPO purified to a 415:280 nm ratio of >0.9 was prepared from equine eosinophils and stored in 0.05 M sodium acetate buffer, pH 4.7-1.0 M sodium chloride at -70°C (25) . EPO was thawed immediately before use and assayed by guaiacol oxidation (26 containing penicillin G (100 U/ml), streptomycin (100 ,g/ ml), 2 mM L-glutamine, and 25% autologous serum (MI99-AS). Cell preparations contained 26±3% (range 14-42%) monocytes, <2% polymorphonuclear leukocytes, and the remainder, lymphocytes, determined as described above.
Human fibroblasts. was then added to each well. After 20 h at 370C in 5% C02-air, the well contents were deposited on glass fiber filter papers using a multiple automated sample harvester (MASH II; Microbiological Associates, Bethesda, MD). Filters were dried, placed in scintillation vials containing 10 ml of Liquifluor (New England Nuclear), and counted in a liquid scintillation counter. All determinations were carried out in quadruplicate and the means were used for statistical analysis.
Measurement of the respiratory burst 0-release. The components of the reaction mixture (see legend to Table IV) were incubated in 12 X 75-mm polystyrene test tubes at 370C in a shaking water bath. Each reaction tube was run in parallel with an identical tube except for the addition of superoxide dismutase (2,500 U/mg, Sigma Chemical Co.) at a final concentration of 25 ,ug/ml. Aliquots, removed when the reaction was initiated and 1 h later, were placed in iced microfuge tubes, cleared by centrifugation (8,000 g for 2 min) and the concentration of ferrocytochrome c was determined spectrophotometrically at 550 nm using E = 2.1 X 104 M`cm-'. Superoxide dismutaseinhibitable ferricytochrome c reduction was used as a measure of 0°production (34) .
Nitroblue tetrazolium (NBT) reduction. Quantitative and qualitative NBT reduction was determined as previously described (2) .
Electron microscopic studies
Peritoneal cell suspensions containing 3 X 106 macrophages in 3 ml M199-FBS were incubated with 6 X 106 Toxo or Toxo/EPO in 12 X 75-mm polystyrene test tubes for 1 h at 370C in 5% C02-air. Cells and organisms were collected by centrifugation (200 g for 10 min), the supernatants discarded, and the pellets fixed in 1.5% glutaraldehyde (Polysciences, Inc., Warrington, PA) in 0.1 M sodium cacodylate buffer, pH 7.0, for 10 min at 4°C. The pellets were washed twice in 0.1 M sodium cacodylate buffer, and then reacted with a mixture containing 0.5 mg/ml diaminobenzidine (Scientific Chemical Co., Huntington Beach, CA), 2 mM glucose and 25 Atg/ml glucose oxidase (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, CA) in 0.05 M Tris buffer, pH 7.6, for 2 h at 22°C. Cells and organisms were then washed and postfixed in osmium tetroxide (Scientific Chemical Co.), dehydrated with ethanol, and collected by low-speed centrifugation before embedding in Epon 812 (Scientific Chemical Co.) for examination with a JEOL 100B electron microscope (Japan Electron Optics Laboratory, Tokyo, Japan) at 60 kV. Unless otherwise indicated, preparations were stained in the block with uranyl acetate and on the section with lead citrate.
Statistical analysis
Data are reported as the mean±standard error. Differences were analyzed for significance using the Student's twotailed t test for independent means (35) .
RESULTS
Binding of EPO to Toxoplasma preparations. T. gondii, preincubated with EPO (Methods) and washed extensively to remove unbound peroxidase, retained a portion of the EPO bound to the surface of the organism. Thus, when these preparations of T. gondii (Toxo/EPO) were examined by peroxidase cytochemistry, diaminobenzidine-positive material was evident as a thin electron-dense rim uniformly coating all organisms (Fig. 1A) . This electron-dense material was E...) FIGURE absent from similarly treated control organisms that had not been preincubated with EPO (Toxo; Fig. 1B) .
The coating of organisms with peroxidase was not toxic under these experimental conditions; thus the cellular detail of the Toxo and Toxo/EPO preparations was equivalent by electron microscopic morphologic criteria. Toxoplasmacidal activity of bound EPO in cell-free systems. Toxo/EPO were rapidly killed on the addition of H202 (0.1 mM) and iodide (10 uM) ( Table  I ). The percentage of viable organisms fell from 89 to 2% as assessed by AO/EB fluorescence microscopy (P < 0.001); similarly, the uptake of [3H]2DG decreased from 9,025 to 1,997 cpm (P < 0.005). This loss of viability was not seen when either H202 or iodide was omitted or when both were added to control Toxo. The toxic effect of H202 and iodide on Toxo/EPO was greatly decreased by the hemeprotein inhibitors aminotriazole, azide, and cyanide, with cyanide the least effective of the inhibitors.
Survival and replication of Toxo and Toxo/EPO in mouse peritoneal macrophages. The clearance of Toxo and Toxo/EPO by resident mouse peritoneal macrophages was investigated to determine if organism-bound peroxidase could enhance the killing of The enhanced killing of Toxo/EPO by macrophages during the initial 6 h after infection was supported by electron microscopic studies (Fig. 4) . The majority of Toxo within macrophages showed no loss of cellular detail 1 h after infection. In contrast, many Toxo/EPO, with peroxidase still evident on their surfaces, showed morphological changes consistent with death of the organism. Toxo/EPO that survived the early postphagocytic period replicated as well as did control Toxo. Thus at 20 h, infected macrophages contained 6.1±0.2 and 6.3±0.2 organisms/vacuole when infected with Toxo and Toxo/EPO.
Uptake of [3H]uracil by macrophages infected with T. gondii is dependent on the survival and intracellular replication of the organisms (36); inhibition of uptake has been used as an index of macrophage toxoplasmacidal activity (37) . As shown in Table II (Table IV) . Indeed, a respiratory burst was not detected by these parameters with either Toxoplasma % . < -,l s<nn preparation, in contrast to that seen with opsonized zymosan. This confirms earlier studies (2) .
Survival and replication of Toxo and Toxo/EPO in normal and MPO-deficient human monocytes. To further elucidate the role of peroxidase in the enhanced destruction of Toxo/EPO by mononuclear phagocytes, monocytes from normal volunteers and from two individuals with hereditary MPO deficiency were infected with preparations of Toxo and Toxo/ EPO (Fig. 5) . When Toxo was used, comparable percentages of normal and MPO-deficient monocytes were infected following the 1 h challenge (12.6 and 14.5%, respectively), and the number of organisms per infected cell was similar (1.2±0.3 and 1.1±0.2, respectively). However, with continued incubation, Toxo was cleared more rapidly from normal than from MPO-deficient cells. Thus at 6 h only 4% of normal monocytes remained infected in contrast with 11% of MPO-deficient monocytes (P < 0.05). At 20 h the difference between the two cell populations was no longer significant. In contrast, when Toxo/EPO was used, organisms were cleared comparably by both cell populations. After a 1-h challenge, the percentages of infected normal and MPO-deficient monocytes were 17.6 and 19.2 and phagocytosis was identical (1.1±0.2 organisms/infected cell for both monocyte populations). However, Toxo-EPO was cleared as well by MPO-deficient monocytes as by normal cells at both 6 (3.8 and 4.9% monocytes infected) and 20 h (3.3 and 4.2% monocytes infected). Thus the toxoplasmacidal defect observed in MPO-deficient monocytes was abolished by coating the organisms with EPO. In contrast to macrophages, the Toxo and Toxo/EPO that survived the early postphagocytic period replicated poorly during the 20-h incubation, both in normal monocytes (1.2±0.2 and 1.1±0.1 organisms/vacuole), and in MPO-deficient monocytes (1.6±0.2 and 1.1±0.1 organisms/vacuole). The cell density of the normal and MPO-deficient monocyte monolayers was comparable at the time of infection (84±18 and 76±12
Peroxidase-mediated Toxoplasmacidal Activity of Mononuclear Phagocytes cells/grid field) and at 6 and 20 h after infection with either Toxo or Toxo/EPO, as assessed both microscopically and by protein content.
In two experiments, monocytes were challenged with heat-killed organisms with and without bound EPO. No difference in the percentage of normal and MPO-deficient cells containing organisms was seen following 1, 3, 6 , and 20 h of incubation; at 20 h no Toxoplasma could be identified. Thus digestion of dead Toxoplasma by both types of monocytes was unaffected by EPO.
Survival and replication of Toxo and Toxo/EPO in CGD monocytes. CGD monocytes were used to investigate the role of the respiratory burst in the enhanced destruction of Toxo/EPO by mononuclear phagocytes. Monocytes from normal volunteers and from two subjects with CGD were incubated with Toxo and Toxo/EPO for 1 h. As shown in Fig. 6 , CGD cells, like MPO-deficient monocytes, had a significant toxoplasmacidal defect at 6 h; however, in contrast to the results with MPO-deficient cells, this toxoplasmacidal defect was not abolished when Toxo/EPO was used. The difference in the percentages of infected normal and CGD monocytes was no longer significant at 20 h. However, the surviving control and EPO-coated organisms replicated better during the 20-h incubation in CGD monocytes (3.3±0.5 and 3.1±0.4 organisms/ vacuole) than in normal monocytes (1.2±0.2 and 1.1±0.3 organisms/vacuole; P < 0.05, CGD vs. normal monocytes for both Toxo and Toxo/EPO). The cell density of the normal and CGD monocyte monolayers was comparable at the time of infection (79±14 and 64±18 cells/grid field) and, for both cell types, the monolayer cell densities and protein contents were comparable at 6 and 20 h following infection with either Toxo or Toxo/EPO.
In two experiments, the clearance of heat-killed Toxoplasma by normal and CGD monocytes at 1, 3, 6, and 20 h was comparable, suggesting that the respiratory burst is not required for digestion under these conditions. The binding of EPO to the dead Toxo- 
DISCUSSION
Earlier studies indicated that the toxic effects of macrophages on T. gondii correlate directly with the ability of these phagocytes to generate°2 and H202 and presumably their more distal reduction (OH') and excitation ('02) products (3, 11) . When the xanthine oxidase system was used as a model of the oxygen-dependent antimicrobial systems of phagocytes, the toxicity of these products of oxygen metabolism (02, H202, OH', '02) was found to be considerably increased by the addition of peroxidase and a halide (38) . This amplification of toxicity by peroxidase also has been observed using Toxoplasma as the target (8) . Since resident peritoneal macrophages (a) lack a granule peroxidase that can be used for microbicidal activity (1), (b) respond to stimulation with a weak respiratory burst (10) , and (c) do not kill or inhibit the replication of intracellular Toxoplasma (2, 3) , an attempt was made to potentiate the toxoplasmacidal activity of these cells by the introduction of peroxidase. EPO was used for this purpose.
EPO was found to bind firmly to the surface of T. gondii with no apparent toxicity to the organism as assessed by vital staining, [3H]2DG uptake, and electron microscopic morphologic evaluation. The predominant membrane proteins of T. gondii are acidic (24) , providing a basis for the firm binding of the strongly cationic EPO to the cell surface. Cationic proteins, including those from eosinophils (39) (40) (41) (42) , can be directly toxic to cells; if this is the case with EPO, the amount bound, under the conditions used here, is inadequate for this effect. Toxoplasma with surfacebound EPO are, however, rapidly killed by the addition of H202 and iodide. H202 was effective under these conditions at a concentration (0.1 mM), which was considerably less than that required to kill organisms without EPO on their surface (50 mM; data not shown). Killing of EPO-coated Toxoplasma was largely prevented by the hemeprotein inhibitors aminotriazole, azide, and cyanide, with cyanide the least effective as noted previously in other EPO-dependent cytotoxic systems (26, 43) .
In contrast to control Toxoplasma, resident mouse peritoneal macrophages were able to kill Toxoplasma with surface-bound EPO, as assessed both microscopically and by [3H]uracil uptake. EPO did not affect the rate of digestion of heat-killed organism, suggesting that its effect on viable organisms is to potentiate killing rather than digestion. Why all EPO-coated organisms are not killed by the macrophages is unclear. This might reflect either heterogeneity in the macrophage population or the ability of Toxoplasma to cap and shed surface-bound molecules (44) .
There are a number of lines of evidence that suggest that the enhanced toxoplasmacidal activity observed when Toxo/EPO is ingested by resident peritoneal macrophages is due to the interaction of macrophagederived H202 with the EPO on the organism surface.
(a) Peroxidase was detected in the phagosome on the surface of the ingested organism by electron microscopic cytochemical studies.
(b) The enhanced toxoplasmacidal activity was inhibited by aminotriazole and azide. These hemeprotein inhibitors are commonly used in concentrations employed here as evidence of peroxidatic mechanisms in phagocytes (15) . Hemeprotein inhibitors also may affect other parasite or macrophage heme-containing enzymes; however, control Toxoplasma incubated with macrophages in the presence of the hemeprotein inhibitors survived and replicated normally, suggesting the absence of a significant effect on organisms or macrophages in the absence of EPO under the conditions used. Azide is also a scavenger of singlet oxygen (45) and hydroxyl radicals (46); however, higher concentrations than those used here are generally required for azide to compete effectively with cellular scavengers of these agents.
(c) Peroxidase appears to be required for the optimum killing of Toxoplasma by monocytes. Thus monocytes from patients with hereditary MPO deficiency. had a toxoplasmacidal defect evident during the initial 6 h postinfection. The toxoplasmacidal defect of MPOdeficient monocytes was completely reversed by EPO bound to the surface of the ingested organisms, emphasizing the role of peroxidase in early postphagocytic toxoplasmicidal events.
(d) A respiratory burst (and presumably H202 production) appears to be required for the enhanced destruction of EPO-coated organisms by mononuclear phagocytes. Thus the toxoplasmacidal defect seen in monocytes that lack a respiratory burst, i.e., from patients with CGD, is unaffected by surface-bound EPO. Furthermore, EPO-coated Toxoplasma survive normally in human fibroblasts, which do not respond to phagocytosis with a respiratory burst. Our data also suggest a role for the respiratory burst in the inhibition of replication of ingested Toxoplasma, as suggested by others (11) . Thus replication of intracellular organisms at 20 h was greatest in the fibroblasts (7.4 organisms/ vacuole), slightly less in the macrophages (6.1 organisms/vacuole), and significantly lower in the monocytes (1.2 organisms/vacuole). Of the various monocyte populations studied here, replication was greatest in CGD monocytes (3.3 organisms/vacuole), cells which do not respond to phagocytosis with a respiratory burst. We were unable to measure enhanced O2 generation or NBT reduction by resident macrophages ingesting Toxo or Toxo/EPO and conclude that toxicity to peroxidase-coated organisms is a more sensitive measure of the small respiratory burst in these cells.
While the studies described here, and those of others (2, 3), emphasize the role of oxygen metabolites in the killing of Toxoplasma by phagocytes and the amplification of this effect by peroxidase, it should be stressed that oxygen-independent antimicrobial systems also appear to be effective against Toxoplasma in monocytes. Thus the toxoplasmacidal activity of CGD monocytes, while depressed, is not abolished, indicating the presence of toxic systems in these cells which are not dependent on the respiratory burst. EPO-coated organisms were not cleared more efficiently by CGD monocytes than were uncoated organisms, suggesting that bound EPO does not render Toxoplasma more susceptible to nonoxidative killing mechanisms. The contrast between the toxoplasmacidal activity of human blood monocytes and resident mouse macrophages indicates that the macrophages in the absence of peroxidase lack effective oxygen-independent and oxygen-dependent mechanisms.
Can the toxicity of resident macrophages be amplified by acquired peroxidase in vivo? This question cannot be answered definitively at the present time; however, several lines of evidence suggest that the mechanism described here may have an in vivo counterpart. Moderate numbers of eosinophils are found in foci of inflammation in human toxoplasmosis (47, 48) . Further, intraperitoneal infection of mice with Toxoplasma (2 X 103) causes an increase in peritoneal fluid eosinophils from 0.1% of total cells (1.6 x 103 eosinophils) to 9% (7.5 X 105 eosinophils) at 5 d postinfection. An influx of neutrophils also occurs while macrophages are the predominant cell type throughout the infection period (unpublished data). Macrophages in inflammatory foci may acquire phagosomal peroxidase by ingesting cellular debris, including the peroxidase-positive granules of neutrophils and eosinophils (21) . Such macrophages are able to iodinate protein (22) , a characteristic of phagocytes with active granule peroxidase (49), but not of normal resident macrophages (50) . As Our findings suggest a mechanism by which peroxidase-positive phagocytes and peroxidase-negative macrophages may interact early in infection and afford some protection to the host before the development of macrophage activation.
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